Jacobson, I.R., Dore, G.J., Foster, G.R., Fried, M.W., Radu, M., Rafalsky, V.V., et al. (2014). Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. THE LANCET, 384(9941), 403-413 [10.1016/S0140-6736(14)60494-3].
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
CRAXI, Antonio;
2014-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0140673614604943-main.pdf
Solo gestori archvio
Dimensione
282.27 kB
Formato
Adobe PDF
|
282.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
